Guardian Pharmacy Services (NYSE:GRDN) Stock Falls 4.9% – Should You Sell?

Guardian Pharmacy Services, Inc. (NYSE:GRDN) shares fell 4.9% during trading on Wednesday. The company traded as low as $39.99 and last traded at $39.8040. 36,665 shares were traded during trading, a decline of 91% from the average daily volume of 426,018 shares. The stock had previously closed at $41.87.

Analyst Ratings Changes

GRDN has been the subject of several recent research reports. Wall Street Zen upgraded shares of Guardian Pharmacy Services from a “hold” rating to a “buy” rating in a report on Saturday. Oppenheimer increased their price objective on Guardian Pharmacy Services from $43.00 to $49.00 and gave the company an “outperform” rating in a research note on Friday, August 7th. Truist Financial raised their price target on shares of Guardian Pharmacy Services from $47.00 to $51.00 and gave the stock a “buy” rating in a research note on Monday, September 21st. Weiss Ratings raised shares of Guardian Pharmacy Services from a “buy (b-)” rating to a “buy (b)” rating in a research note on Thursday, October 8th. Finally, KeyCorp started coverage on Guardian Pharmacy Services in a research report on Tuesday, September 22nd. They issued an “overweight” rating and a $52.00 price objective for the company. Nine analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $45.57.

Guardian Pharmacy Services Price Performance

The firm’s 50-day moving average price is $40.86 and its 200-day moving average price is $39.94. The company has a market cap of $1.98 billion, a price-to-earnings ratio of 38.51, a price-to-earnings-growth ratio of 2.10 and a beta of 0.03.

Guardian Pharmacy Services (NYSE:GRDN) last posted its quarterly earnings data on Thursday, August 6th. The company reported $0.29 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.26 by $0.03. Guardian Pharmacy Services had a net margin of 4.50% and a return on equity of 29.97%. The company had revenue of $351.77 million for the quarter, compared to analyst estimates of $340.45 million. On average, sell-side analysts anticipate that Guardian Pharmacy Services, Inc. will post 1.18 earnings per share for the current year.

Institutional Investors Weigh In On Guardian Pharmacy Services

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Jennison Associates LLC raised its holdings in Guardian Pharmacy Services by 609.5% during the 1st quarter. Jennison Associates LLC now owns 822,784 shares of the company’s stock worth $30,986,000 after buying an additional 706,823 shares during the period. Braun Stacey Associates Inc. bought a new stake in Guardian Pharmacy Services during the second quarter worth approximately $14,234,000. Sei Investments Co. boosted its stake in Guardian Pharmacy Services by 40.5% during the 1st quarter. Sei Investments Co. now owns 358,181 shares of the company’s stock valued at $13,489,000 after purchasing an additional 103,177 shares during the period. Dimensional Fund Advisors LP grew its position in Guardian Pharmacy Services by 200.0% during the first quarter. Dimensional Fund Advisors LP now owns 208,594 shares of the company’s stock worth $7,855,000 after buying an additional 139,070 shares in the last quarter. Finally, Ranger Investment Management L.P. bought a new stake in shares of Guardian Pharmacy Services in the 2nd quarter valued at approximately $7,263,000.

About Guardian Pharmacy Services

Guardian Pharmacy Services, Inc is a provider of pharmacy services focused primarily on residents of long-term care and other institutional healthcare settings. Through its network of pharmacies, the company supplies prescription medications and related pharmacy support to assisted living communities, skilled nursing facilities, behavioral health organizations, and other care providers.

The company’s services include medication dispensing and packaging, prescription delivery, medication management, clinical pharmacy support, and technology-enabled tools designed to help caregivers and healthcare professionals manage residents’ medication regimens.